MARTIGNONI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 13.738
EU - Europa 12.497
AS - Asia 8.280
SA - Sud America 1.305
AF - Africa 128
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 17
Totale 35.992
Nazione #
US - Stati Uniti d'America 13.534
GB - Regno Unito 3.900
SG - Singapore 3.291
CN - Cina 3.068
RU - Federazione Russa 2.387
IT - Italia 1.472
BR - Brasile 1.126
SE - Svezia 1.048
HK - Hong Kong 865
FR - Francia 833
DE - Germania 793
FI - Finlandia 727
IE - Irlanda 709
VN - Vietnam 261
KR - Corea 245
UA - Ucraina 230
CA - Canada 123
JP - Giappone 88
TR - Turchia 86
BE - Belgio 82
IN - India 79
NL - Olanda 76
AR - Argentina 59
BD - Bangladesh 53
ES - Italia 50
PL - Polonia 47
EC - Ecuador 42
MX - Messico 42
ZA - Sudafrica 38
ID - Indonesia 34
IQ - Iraq 34
AT - Austria 25
IR - Iran 24
AU - Australia 21
LT - Lituania 21
IL - Israele 20
MA - Marocco 18
CZ - Repubblica Ceca 17
VE - Venezuela 17
SA - Arabia Saudita 16
PY - Paraguay 15
EU - Europa 14
CL - Cile 13
CO - Colombia 13
TG - Togo 13
KE - Kenya 12
AZ - Azerbaigian 11
PE - Perù 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
LV - Lettonia 10
UZ - Uzbekistan 10
EG - Egitto 9
TN - Tunisia 9
HN - Honduras 8
JO - Giordania 8
BG - Bulgaria 7
CH - Svizzera 7
HU - Ungheria 7
PH - Filippine 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
OM - Oman 6
PS - Palestinian Territory 6
DK - Danimarca 5
HR - Croazia 5
MY - Malesia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PA - Panama 5
TW - Taiwan 5
CI - Costa d'Avorio 4
EE - Estonia 4
IM - Isola di Man 4
KZ - Kazakistan 4
LK - Sri Lanka 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
CM - Camerun 3
DZ - Algeria 3
LU - Lussemburgo 3
MT - Malta 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 35.954
Città #
Southend 3.516
Jacksonville 1.900
Chandler 1.667
Singapore 1.371
Dallas 1.285
Woodbridge 1.198
Ann Arbor 1.073
Hong Kong 858
Ashburn 787
Dublin 706
Houston 625
Beijing 551
Moscow 487
Lawrence 312
Princeton 312
Wilmington 304
Nanjing 251
Jinan 242
Los Angeles 239
New York 203
Shenyang 186
Verona 158
The Dalles 154
Helsinki 147
Munich 146
Hebei 132
Tianjin 127
Buffalo 126
Milan 120
São Paulo 112
Rome 106
Sindelfingen 106
Redondo Beach 103
Changsha 94
Dearborn 93
Ningbo 92
Zhengzhou 90
Columbus 85
Ho Chi Minh City 83
Brussels 80
Tokyo 79
Haikou 78
Nanchang 76
Taizhou 72
Santa Clara 71
Boardman 68
Lancaster 66
Guangzhou 63
Jiaxing 63
Turku 60
Hanoi 56
Redwood City 51
Bologna 50
Norwalk 48
San Francisco 48
Taiyuan 48
Hangzhou 47
London 47
Seoul 44
Redmond 41
Montreal 39
Chicago 38
Warsaw 38
Rio de Janeiro 37
Seattle 37
Toronto 37
Nuremberg 33
Fuzhou 32
Brooklyn 31
Denver 31
Phoenix 31
Falls Church 27
Frankfurt am Main 27
Belo Horizonte 25
Council Bluffs 25
Detroit 25
Johannesburg 25
Stockholm 25
Lanzhou 24
Brasília 23
Amsterdam 22
Ankara 21
Atlanta 20
Cambridge 20
Augusta 19
Chennai 19
Fairfield 19
Madrid 19
Washington 19
Campinas 18
Düsseldorf 18
Jakarta 18
Mexico City 18
San Mateo 18
Boston 17
Guayaquil 16
Orem 16
Porto Alegre 16
Dong Ket 15
Bari 14
Totale 22.375
Nome #
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 611
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 335
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 258
Schwannoma del rene 213
Tumors characterized by the presence of HMB45-positive perivascular epithelioid cell (PEC) - A novel entity in surgical pathology 210
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 207
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 198
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 192
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 190
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 187
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 181
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 181
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 177
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 172
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 171
Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis 170
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 169
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 169
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 167
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 166
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 166
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 166
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 165
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 165
Chondroid syringoma with extensive ossification 165
CD10 is expressed in a subset of chromophobe renal cell carcinomas 164
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 163
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 161
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 161
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 161
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 159
The perivascular epithelioid cell and related lesions 156
Adenocarcinoma of the paraurethral glands: a case report 156
Perivascular epithelioid cell tumor (PEComa) in the genitourinary tract 155
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 155
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 154
Endocrine neoplasms of the pancreas: pathologic and genetic features. 154
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 153
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 153
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 153
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 153
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 152
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 152
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 151
Due casi di neoplasia primitiva maligna con aspetti gliali e neuronali 150
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 150
Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-oncologico del Nord-est 149
Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients 149
Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast 148
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 148
bcl-2 expression in pleural and extrapleural solitary fibrous tumours [see comments] 147
S100P expression in cholangiocarcinoma 147
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 147
[Diagnostic and prognostic markers in renal tumors] 146
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 146
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 145
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 144
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 144
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 143
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 143
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 142
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 142
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 142
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 142
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 141
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 141
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 141
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 139
Expression of GATA-3 among renal cell and urothelial neoplasms 139
False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of antimelanoma monoclonal antibody HMB45 139
Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study 138
Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis 137
Mucinous cystic tumor of the pancreas recurring after 11 years as cystadenocarcinoma with foci of choriocarcinoma and osteoclast-like giant cell tumor 137
Renal Angiomyolipoma with epithelioid sarcomatous transformation and metastases. Demonstration of the same genetic defects in the primary and metastatic lesions 137
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy 137
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 137
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 137
Carcinomi renali papillari con aree di cellule chiare 137
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 137
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. 136
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies 136
Liver Metastases From Renal Oncocytoma With Vascular Extension 136
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 135
External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. 135
Preoperative diagnosis of renal angiomyolipoma: fine needle aspiration cytology and immunocytochemical characterization 133
Rectal cancer: pathological features and their relationship to prognosis and treatment 133
Renal Perivascular Epithelioid Cell Tumors [(PEComa), so Called Epithelioid Angiomyolipoma (EAML)]: Analysis of 61 Cases Including 44 with Pure/Predominant Epithelioid (P-PEComa) Morphology and Parameters Associated with Malignant Outcome 133
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 132
Mathematical models for prognostic prediction in patients with renal cell carcinoma. 131
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma 131
Espressione di CD23 nelle neoplasie cutanee annessiali 131
Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney 130
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 129
Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. 128
Subepithelial Pelvic Hematoma (Antopol-Goldman Lesion) Simulating Renal Neoplasm: Report of a Case and Review of the Literature 128
La perdita del 9p è un fattore prognostico nei pazienti affetti da carcinoma a cellule chiare del rene 128
The route to personalized medicine in bladder cancer: where do we stand? 128
AR-V7 and prostate cancer: The watershed for treatment selection? 128
Cathepsin K expression in clear cell "sugar" tumor (PEComa) of the lung 128
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 128
Totale 15.862
Categoria #
all - tutte 129.230
article - articoli 110.491
book - libri 0
conference - conferenze 17.305
curatela - curatele 0
other - altro 149
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.285
Totale 258.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.775 0 0 0 0 397 313 59 233 158 48 426 141
2021/20222.598 255 655 19 317 102 109 45 151 78 63 220 584
2022/20234.954 402 463 497 779 545 1.141 40 322 502 65 121 77
2023/20242.265 114 210 188 262 298 305 130 141 41 97 336 143
2024/20256.331 361 410 241 1.039 294 201 252 237 1.002 488 562 1.244
2025/20267.359 1.346 1.034 1.504 3.160 315 0 0 0 0 0 0 0
Totale 36.383